Edition:
United Kingdom

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

8.92USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$8.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,152
52-wk High
$11.34
52-wk Low
$5.82

Select another date:

Tue, Nov 14 2017

BRIEF-Oramed receives approval for clinical study to treat NASH

* Oramed receives regulatory approval to conduct clinical study for treatment of NASH with its oral insulin capsule

BRIEF-Oramed pharmaceuticals ‍concludes its meeting with U.S. FDA regarding its oral insulin formulation​

* ‍Concluded its meeting with U.S. FDA regarding ORMD-0801, company's novel oral insulin formulation​

BRIEF-Oramed Pharmaceuticals Inc's CFO Yifat Zommer resigned from her positions with co per personal reasons

* Oramed Pharmaceuticals Inc - on July 18, yifat zommer, cfo of co resigned from her positions with co per personal reasons, effective August 1, 2017

BRIEF-Oramed announces dual-listing on Tel Aviv stock exchange

* Oramed Pharmaceuticals Inc - ‍Based on current market capitalization of company, it is expected that Oramed will be included in TA SME-60 index​

BRIEF-Oramed granted Japanese patent for combination insulin and glp-1 analog capsule

* Oramed granted Japanese patent for combination insulin and glp-1 analog capsule

Select another date: